Monday, September 8, 2014

Hot Performing Stocks To Buy For 2015

Hot Performing Stocks To Buy For 2015: Otoc Ltd (OTC)

OTOC Limited through its wholly owned subsidiaries OTOC Group Pty Ltd and Whelans (WA) Pty Ltd (Whelans) provides construction and turnkey camp/ village installations, environmental, surveying, mapping, town planning, engineering, project delivery and specialist consulting services across the infrastructure, resources and energy sectors. The Company operates in two segments: OTOC Operations and Whelans Consulting Operations. OTOC Operations (OTOC) provides camp/village installations to the Western Australian resources and infrastructure sector. Whelans Consulting Operations (Whelans) provides surveying, mapping and town planning services throughout Western Australian. In July 2013, the Company announced that its wholly owned subsidiary OTOC Australia has expanded its Facilities Division through the acquisition of full ownership of a 700 person commercial kitchen/diner facility. Advisors' Opinion:
  • [By Holly LaFon]

    Perrigo (PRGO) is a global manufacturer of over-the-counter (OTC) store brand and generic prescription pharmaceuticals, infant formulas, nutritional products and active pharma ingredients. The company is the dominant player in the OTC drug market with the largest distribution network and broadest range of product offerings. The OTC store brands have increased their market share by about 1-2% annually at the expense of national name product given their superior value proposition to both the consumer and retailers. Perrigo has numerous growth drivers over the next few years including the continued penetration of OTC store brands and introduction of new product categories. The stock sells at a reasonable valuation, in our opinion, given the company's strong management team, financial returns and long-term growth prospects.

  • [By David Dittman]

    Crown Resorts is a buy all the way up to USD16.50 on the Australian Securities Exchange (ASX) using the symbol CWN and on the US over-the-counter! (OTC) market using the symbol CWLDF.

  • [By Holly LaFon]

    Perrigo (PRGO) is a global manufacturer of over-the-counter (OTC) store brand and generic prescription pharmaceuticals, infant formulas, nutritional products and active pharma ingredients. The company is the dominant player in the OTC drug market with the largest distribution network and broadest range of product offerings. The OTC store brands have increased their market share by about 1-2% annually at the expense of national name product given their superior value proposition to both the consumer and retailers. Perrigo has numerous growth drivers over the next few years including the continued penetration of OTC store brands and introduction of new product categories. The stock sells at a reasonable valuation, in our opinion, given the company's strong management team, financial returns and long-term growth prospects.

  • [By Holly LaFon]

    During the quarter, Perrigo (PRGO) announced strong September quarter adjusted earnings growth of 20%. We say adjusted because the Company incurred what we believe are non-recurring charges related to the recent purchase of Elan Corporation, which is a branded-drug company domiciled in Ireland. Upon the closing of this purchase, Perrigo has re-domiciled itself in Ireland, with an effective tax rate meaningfully below what they were subjected to in the U.S. Given that the Company actively pursues a strategy of inorganic growth as much as it pursues organic growth - having acquired six new businesses over the past 18 months (including Elan) - we expect that this new tax structure should make future acquisitions, particularly those U.S. based businesses, much more attractive. Further, Perrigos core business, which includes private-label over-the-counter (OTC) pharmaceuticals and infant formula, drove much of the year-over-year growth. The Companys unrivaled scale in manufacturing and marketing of store-branded offerings continues to enable retailers to mimic the valu! e proposi! tion of OTC pharmaceuticals and infant formula. This store-brand conversion is a multi-year trend that we expect will continue for the foreseeable future as consumers continue to become more value-conscious, yet more comfortable with store-brand quality that Perrigo helps engineer.

  • source from Top Penny Stocks For 2015:http://www.topstocksforum.com/hot-performing-stocks-to-buy-for-2015-2.html

No comments:

Post a Comment